Healthcare -
Biotechnology - NASDAQ - US
$ 12.69
1.2 %
$ 475 M
Market Cap
8.81
P/E
TRDA - SHORT-TERM DEBT
Short-term Debt TRDA - Entrada Therapeutics, Inc.
14.9 M
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR